Skip to main content
. Author manuscript; available in PMC: 2021 Jun 11.
Published in final edited form as: Eur J Nucl Med Mol Imaging. 2016 Mar 21;43(10):1784–1791. doi: 10.1007/s00259-016-3357-x

Table 1.

Patient characteristics

Patient no. Sex Tested negative Age (years)
Location of primary Hypersecretion Time to metastasis (years) Location of metastases
Diagnosis Time of study
1 m SDHx, VHL 61 75 Right adrenal NM, NE, DA, CgA 12 A/P
2 f SDHx 52 55 Left adrenal NM, NE, CgA 3 A/P, B
3 f SDHx 54 54 Left para-adrenal NM, NE, CgA 0 A/P, B
4 m SDHx, MEN, VHL, TMEM 127 20 37 Right para-adrenal NM 0 A/P, B, Li, Lu
5 m SDHx, MEN, VHL 27 30 Unknown NE, NM, DA, CgA 0 A/P, B, Li, Me
6 f SDHx 21 46 Right glomus jugulare None 9 A/P, B, Me, Ne
7 f SDHx, MEN, VHL, MAX, TMEM 127 52 64 Left adrenal NM, NE, DA, MTT, CgA 6 A/P, B, Li, Lu
8 f SDHx, MAX 38 47 Left adrenal NM, MN, CgA 7 B
9 f SDHx 12 31 Left para-adrenal CgA, 4 A/P, B, Lu
10 m SDHx 56 59 Right adrenal NM, MN, NE, DA, CgA 0 A/P, B, Lu, Ne
11 m SDHx 42 52 Unknown DA, CgA, MTT 5 A/P, B, Lu, Me, Ne
12 m SDHx 49 52 Right retroperitoneal CgA 0 B, Li
13 m SDHx, VHL 54 61 Left adrenal NM, NE, CgA, DA 0 A/P, B, Li, Lu, Me
14 m SDHx, MAX 70 73 Left adrenal NM, NE, CgA, DA 0 A/P, Lu, Me
15 m SDHx 34 35 Left retroperitoneal NM, NE, MN, Epi, DA, CgA 0 A/P, B, Li, Lu
16 m SDHx 31 43 Right adrenal NM, NE, DA, CgA 6 A/P, B, Me
17 m SDHx, VHL 23 25 Right adrenal NM, NE, DA, CgA, MTT 0 A/P, B, Li, Lu
18 m SDHx 38 39 Right para-adrenal NM, CgA 0 A/P, B, Li, Me
19 m SDHx 43 64 Right adrenal NM, NE, MN, Epi, DA, CgA, MTT 15 A/P, B
20 m SDHx 34 41 Left adrenal MTT 5 A/P, B
21 f SDHx 63 64 Left adrenal NM, NE, Epi, CgA, MTT 0 B, Li
22 m SDHx 37 39 Right adrenal NM, DA 2 B, Li, Lu

A/P abdominal/pelvic compartment, B bones, CgA chromogranin A, DA dopamine, Epi epinephrine, Li liver, Lu lungs, m male, MAX myc-associated factor X, Me mediastinum, MTT methoxytyramine, Ne neck, NE norepinephrine, NM normetanephrine, TMEM 127 trans-membrane protein 127